Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.96
10.05.24
-
10.05.25
-4.22%
11.05.24

Could be worthwhile Investment >10% per year
Global_Player 
10.05.24 50%
sell
Agba Group Holding Ltd.

Start price
Target price
Perf. (%)
€2.90
30.04.24
-
30.04.25
12.41%
11.05.24

Good culture
Risky Investment
No uniques
me8 
30.04.24 0%
buy
Viking Therapeutics Inc

Start price
Target price
Perf. (%)
€69.50
29.04.24
€100.00
31.03.26
-0.75%
03.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
29.04.24 50%
buy
Biodexa Pharmaceuticals Plc

Start price
Target price
Perf. (%)
€1.09
29.04.24
-
29.04.25
-14.22%
11.05.24

Capable Management
Could be worthwhile Investment >10% per year
Little innovation
me8 
29.04.24 0%
buy
Super Micro Computer

Start price
Target price
Perf. (%)
€812.90
29.04.24
€1,000.00
29.04.25
-8.82%
11.05.24

Could be very worthwhile Investment >20% year
Higher EBIT margin than peer group
Capable Management
Low dividend yield expected
skatcup 
29.04.24 80%
buy
Marathon Digital Holdings

Start price
Target price
Perf. (%)
€17.72
29.04.24
€25.00
29.04.25
-10.21%
11.05.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Some uniques
Risky balance sheet
skatcup 
29.04.24 80%
buy
Northern Data AG

Start price
Target price
Perf. (%)
€25.75
27.04.24
€50.00
27.04.25
2.72%
11.05.24

Revenue decline/stagnation expected
negative Cash Flow expected
Increased challenges to pay loans and raise capital
Higher risks for its business
mixitrader 
27.04.24 50%
sell
Data Modul AG

Start price
Target price
Perf. (%)
€34.40
27.04.24
-
27.04.25
2.91%
11.05.24

Probably not worthwhile Investment
Little Investments for future growth
Little known brand
Lower EBIT Margin than peer group
kostojunior 
27.04.24 0%
buy
Gamestop Corp.

Start price
Target price
Perf. (%)
€10.90
27.04.24
-
27.04.25
48.67%
11.05.24

Could be worthwhile Investment >10% per year
melinda 
27.04.24 10%
buy
Bastide Le Confort

Start price
Target price
Perf. (%)
€17.88
27.04.24
-
27.04.25
8.84%
11.05.24

Could be worthwhile Investment >10% per year
melinda 
27.04.24 10%
buy
JFE Holdings Inc

Start price
Target price
Perf. (%)
€13.90
27.04.24
-
27.04.25
-2.16%
11.05.24

Could be worthwhile Investment >10% per year
melinda 
27.04.24 10%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€3.60
25.04.24
-
25.04.25
-2.00%
27.04.24

Could be worthwhile Investment >10% per year
Global_Player 
25.04.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€2.68
24.04.24
-
24.04.25
4.63%
26.04.24

Could be worthwhile Investment >10% per year
Vassago1 
24.04.24 50%
buy
Plug Power Inc.

Start price
Target price
Perf. (%)
€2.49
23.04.24
€3.00
23.04.25
-8.41%
27.04.24

Good rating
Growths much faster than the competition
Leading role in innovation
Very good company culture
skatcup 
23.04.24 80%
buy
Fate Therapeutics Inc.

Start price
Target price
Perf. (%)
€4.50
19.04.24
-
19.04.25
-12.02%
10.05.24

Could be very worthwhile Investment >20% year
bundfuture 
19.04.24 50%
buy
Mersana Therapeutics

Start price
Target price
Perf. (%)
€3.06
19.04.24
-
19.04.25
-20.98%
10.05.24

Could be worthwhile Investment >10% per year
bundfuture 
19.04.24 50%
buy
Viracta Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.75
15.04.24
€3.00
31.10.25
-
15.04.24

Could be very worthwhile Investment >20% year
BiotechBee 
15.04.24 60%
sell
Delticom AG

Start price
Target price
Perf. (%)
€2.06
15.04.24
-
15.04.25
22.33%
27.04.24

High valuation
Probably not worthwhile Investment
Low dividend yield expected
negative Cash Flow expected
kostojunior 
15.04.24 0%
sell
Fair Value Reit-Ag

Start price
Target price
Perf. (%)
€3.66
15.04.24
-
15.04.25
2.73%
27.04.24

Medium risks for its business
negative Cash Flow expected
EBIT decline/stagnation expected
Increased challenges to pay loans and raise capital
kostojunior 
15.04.24 0%
buy
Alba SE

Start price
Target price
Perf. (%)
€10.50
15.04.24
€15.00
15.04.25
-4.76%
27.04.24

Revenue growth >5% per year expected
Future proof or reliable business model
EBIT growth >5% per year expected
Top 10 in its market
kostojunior 
15.04.24 60%
sell
Liquidia Technologies Inc

Start price
Target price
Perf. (%)
€13.78
13.04.24
€12.00
13.04.25
-18.00%
27.04.24

Probably not worthwhile Investment
EBIT decline/stagnation expected
Low dividend yield expected
Revenue decline/stagnation expected
nvestor 
13.04.24 50%
sell
Adaptimmune Therapeutics PLC ADR

Start price
Target price
Perf. (%)
€1.07
13.04.24
€1.00
13.04.25
-2.80%
27.04.24

Probably not worthwhile Investment
Lower EBIT Margin than peer group
Bad rating
ROE lower than 10% per year
nvestor 
13.04.24 50%
sell
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.51
13.04.24
€2.00
13.04.25
-0.66%
27.04.24

negative Cash Flow expected
Few uniques
Growths slower than the competition
Below average Marketposition
nvestor 
13.04.24 50%
buy
Deutsche Rohstoff AG

Start price
Target price
Perf. (%)
€40.70
12.04.24
€42.00
12.04.25
6.14%
24.04.24

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Rising EBIT margin expected
Fair valuation
Traumtanz 
12.04.24 50%
buy
Enlivex Therapeutics Ltd.

Start price
Target price
Perf. (%)
€1.72
11.04.24
-
11.04.25
-12.21%
14.04.24

Could be worthwhile Investment >10% per year
Wolf_of_WS 
11.04.24 50%